These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

423 related items for PubMed ID: 12239620

  • 1. Soy isoflavone genistein modulates cell cycle progression and induces apoptosis in HER-2/neu oncogene expressing human breast epithelial cells.
    Katdare M, Osborne M, Telang NT.
    Int J Oncol; 2002 Oct; 21(4):809-15. PubMed ID: 12239620
    [Abstract] [Full Text] [Related]

  • 2. Translocation of Bax to mitochondria induces apoptotic cell death in indole-3-carbinol (I3C) treated breast cancer cells.
    Rahman KM, Aranha O, Glazyrin A, Chinni SR, Sarkar FH.
    Oncogene; 2000 Nov 23; 19(50):5764-71. PubMed ID: 11126363
    [Abstract] [Full Text] [Related]

  • 3. Differential sensitivity of normal and malignant breast epithelial cells to genistein is partly mediated by p21(WAF1).
    Upadhyay S, Neburi M, Chinni SR, Alhasan S, Miller F, Sarkar FH.
    Clin Cancer Res; 2001 Jun 23; 7(6):1782-9. PubMed ID: 11410520
    [Abstract] [Full Text] [Related]

  • 4. Bcl-2 overexpression sensitizes MCF-7 cells to genistein by multiple mechanisms.
    Tophkhane C, Yang S, Bales W, Archer L, Osunkoya A, Thor AD, Yang X.
    Int J Oncol; 2007 Oct 23; 31(4):867-74. PubMed ID: 17786319
    [Abstract] [Full Text] [Related]

  • 5. Alterations of estrogen receptors, progesterone receptors and c-erbB2 oncogene protein expression in ductal carcinomas of the breast.
    Hussein MR, Abd-Elwahed SR, Abdulwahed AR.
    Cell Biol Int; 2008 Jun 23; 32(6):698-707. PubMed ID: 18296077
    [Abstract] [Full Text] [Related]

  • 6. Preventive efficacy of receptor class selective retinoids on HER-2/neu oncogene expressing preneoplastic human mammary epithelial cells.
    Jinno H, Steiner MG, Nason-Burchenal K, Osborne MP, Telang NT.
    Int J Oncol; 2002 Jul 23; 21(1):127-34. PubMed ID: 12063559
    [Abstract] [Full Text] [Related]

  • 7. Anti-Her-2/neu antibody induces apoptosis in Her-2/neu overexpressing breast cancer cells independently from p53 status.
    Brodowicz T, Kandioler D, Tomek S, Ludwig C, Rudas M, Kunstfeld R, Koestler W, Hejna M, Budinsky A, Wiltschke C, Zielinski CC.
    Br J Cancer; 2001 Nov 30; 85(11):1764-70. PubMed ID: 11742500
    [Abstract] [Full Text] [Related]

  • 8. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
    Menendez JA, Mehmi I, Atlas E, Colomer R, Lupu R.
    Int J Oncol; 2004 Mar 30; 24(3):591-608. PubMed ID: 14767544
    [Abstract] [Full Text] [Related]

  • 9. Effects of genistein on the growth and cell cycle progression of normal human lymphocytes and human leukemic MOLT-4 and HL-60 cells.
    Traganos F, Ardelt B, Halko N, Bruno S, Darzynkiewicz Z.
    Cancer Res; 1992 Nov 15; 52(22):6200-8. PubMed ID: 1330289
    [Abstract] [Full Text] [Related]

  • 10. Cytotoxic activity of epidermal growth factor-genistein against breast cancer cells.
    Uckun FM, Narla RK, Jun X, Zeren T, Venkatachalam T, Waddick KG, Rostostev A, Myers DE.
    Clin Cancer Res; 1998 Apr 15; 4(4):901-12. PubMed ID: 9563884
    [Abstract] [Full Text] [Related]

  • 11. Genistein induced molecular changes in a squamous cell carcinoma of the head and neck cell line.
    Alhasan SA, Ensley JF, Sarkar FH.
    Int J Oncol; 2000 Feb 15; 16(2):333-8. PubMed ID: 10639578
    [Abstract] [Full Text] [Related]

  • 12. 3,3'-diindolylmethane and paclitaxel act synergistically to promote apoptosis in HER2/Neu human breast cancer cells.
    McGuire KP, Ngoubilly N, Neavyn M, Lanza-Jacoby S.
    J Surg Res; 2006 May 15; 132(2):208-13. PubMed ID: 16580691
    [Abstract] [Full Text] [Related]

  • 13. [Proliferation inhibition and apoptosis onset in human ovarian carcinoma cell line SKOV3 induced by Genistein].
    Li Y, Mi C.
    Ai Zheng; 2003 Jun 15; 22(6):586-91. PubMed ID: 12948406
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Inhibition of aberrant proliferation and induction of apoptosis in HER-2/neu oncogene transformed human mammary epithelial cells by N-(4-hydroxyphenyl)retinamide.
    Jinno H, Steiner MG, Mehta RG, Osborne MP, Telang NT.
    Carcinogenesis; 1999 Feb 15; 20(2):229-36. PubMed ID: 10069458
    [Abstract] [Full Text] [Related]

  • 16. Monoclonal antibody to HER-2/neureceptor modulates repair of radiation-induced DNA damage and enhances radiosensitivity of human breast cancer cells overexpressing this oncogene.
    Pietras RJ, Poen JC, Gallardo D, Wongvipat PN, Lee HJ, Slamon DJ.
    Cancer Res; 1999 Mar 15; 59(6):1347-55. PubMed ID: 10096569
    [Abstract] [Full Text] [Related]

  • 17. Silibinin upregulates the expression of cyclin-dependent kinase inhibitors and causes cell cycle arrest and apoptosis in human colon carcinoma HT-29 cells.
    Agarwal C, Singh RP, Dhanalakshmi S, Tyagi AK, Tecklenburg M, Sclafani RA, Agarwal R.
    Oncogene; 2003 Nov 13; 22(51):8271-82. PubMed ID: 14614451
    [Abstract] [Full Text] [Related]

  • 18. Role of coordinated molecular alterations in the development of androgen-independent prostate cancer: an in vitro model that corroborates clinical observations.
    Shi Y, Chatterjee SJ, Brands FH, Shi SR, Pootrakul L, Taylor CR, Datar R, Cote RJ.
    BJU Int; 2006 Jan 13; 97(1):170-8. PubMed ID: 16336351
    [Abstract] [Full Text] [Related]

  • 19. Effects of genistein and synergistic action in combination with eicosapentaenoic acid on the growth of breast cancer cell lines.
    Nakagawa H, Yamamoto D, Kiyozuka Y, Tsuta K, Uemura Y, Hioki K, Tsutsui Y, Tsubura A.
    J Cancer Res Clin Oncol; 2000 Aug 13; 126(8):448-54. PubMed ID: 10961387
    [Abstract] [Full Text] [Related]

  • 20. Switching off HER-2/neu in a tetracycline-controlled mouse tumor model leads to apoptosis and tumor-size-dependent remission.
    Schiffer IB, Gebhard S, Heimerdinger CK, Heling A, Hast J, Wollscheid U, Seliger B, Tanner B, Gilbert S, Beckers T, Baasner S, Brenner W, Spangenberg C, Prawitt D, Trost T, Schreiber WG, Zabel B, Thelen M, Lehr HA, Oesch F, Hengstler JG.
    Cancer Res; 2003 Nov 01; 63(21):7221-31. PubMed ID: 14612517
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.